Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sarmistha Sanyal"'
Autor:
Ru Chen, Sarmistha Sanyal, Shashi Amur, Aliza Thompson, Kylie Haskins, Joachim H. Ix, Laurie Muldowney
The Biomarker Qualification Program was established at the Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) to expedite the integration of promising biomarkers across multiple drug development programs. The first set
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba8fc885a9812cc52717d7983db2f865
https://europepmc.org/articles/PMC6226328/
https://europepmc.org/articles/PMC6226328/
Autor:
Sarmistha Sanyal, Marianne H Noone, Susan McCune, James Kaiser, ShaAvhrée Buckman-Garner, Aloka Chakravarty, Shashi Amur
Publikováno v:
Biomarkers in Medicine. 9:1095-1105
The traditional route for regulatory acceptance of biomarkers in drug development is through submission of biomarker data in drug approval submissions in the context of a single drug development program. The US FDA's Critical Path Initiative called f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4ebc21217fdedd443363b215c7a61d
https://doi.org/10.2217/bmm.15.90
https://doi.org/10.2217/bmm.15.90
Autor:
Leonid V. Chernomordik, Kamran Melikov, Bokkee Eun, Santosh Kumar Verma, Claudia Gebert, Evgenia Leikina, Michael M. Kozlov, Vladimir A. Lizunov, Karl Pfeifer, Sarmistha Sanyal
Publikováno v:
The Journal of Cell Biology
Annexins A1 and A5 are important for initial lipid mixing, whereas subsequent stages of myoblast fusion depend on dynamin, phosphatidylinositol(4,5)bisphosphate, and cellular metabolism.
Myoblast fusion into multinucleated myotubes is a crucial
Myoblast fusion into multinucleated myotubes is a crucial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0d268d2b2c60abfbda5e963ac09daa
http://europepmc.org/articles/PMC3542790
http://europepmc.org/articles/PMC3542790